60
In band
Moving averages
SMA 200$8.60+31.63%
Company profile
Novavax, Inc., a biotechnology company, focuses on the discovery, development and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company is headquartered in Gaithersburg, Maryland.
SectorHealthcare
IndustryBiotechnology
Market cap$1.55B
P/E ratioNone
EPS$-1.55
Beta2.45
Dividend yield0.00%
52-week high$11.97
52-week low$6.20
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 43
VRTX
Vertex Pharmaceuticals Inc
RSI 38
CRSP
CRISPR Therapeutics AG
RSI 46
IOVA
Iovance Biotherapeutics Inc
RSI 66
MRNA
Moderna Inc
RSI 60
VKTX
Viking Therapeutics Inc
RSI 39
SRPT
Sarepta Therapeutics Inc
RSI 37
EDIT
Editas Medicine Inc
RSI 49
IBRX
ImmunityBio Inc
RSI 61
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 63
RSI alerts for NVAX
Get an email the moment Novavax Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 13 September 2026 at 4:08 AM EDT